NEW THERAPY FOR RARE GASTROINTESTINAL STROMAL TUMOURS APPROVED IN SINGAPORE

/PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics Asia (ST) is pleased to announce that a new therapy to treat rare...

Related Keywords

Australia ,New Zealand ,Singapore ,Richard Quek ,South East Asia ,Carlo Montagner ,Health Sciences Authority ,European Society For Medical Oncology Virtual Meeting ,Singapore Health Sciences Authority ,Deciphera Pharmaceuticals ,Corporate Affairs Emma Power ,Gi Cancer Institute Australia ,Specialised Therapeutics Asia ,Executive Officer Carlo Montagner ,Manager Communications ,Specialised Therapeutics ,Response Evaluation Criteria ,Solid Tumors ,Lancet Oncol ,Product Information ,Medical Oncology Virtual Meeting ,Institute Australia ,Clin Cancer ,